In keeping our patients informed during the pandemic, we are keeping our eyes on interesting developments that correspond with Chattanooga Integrated Medicine Center services. Recently, we learned a team of doctors at the University of Miami won emergency federal approval to use stem cell therapy on patients suffering severe lung inflammation from COVID-19. The treatments began in mid April on a dozen patients.

The UM Miller School of Medicine doctors are proposing to block the lung inflammation using an intravenous infusion of stem cells and the Food and Drug Administration granted them immediate authorization for the trial.

Dr. Hall and our team are well versed in the known benefits of Regenerative Medicine Therapy, which is why we already offer a series of treatments and treatment plans for a large variety of ailments including: tendinopathy, acute and chronic soft-tissue injuries, enhancement of healing after ligament reconstruction, and knee osteoarthritis. There is a lot of hope that Regenerative Medicine may really benefit COVID-19 patients because mesenchymal stem cells (those used in the therapy)  are known to have anti-inflammatory qualities that may help calm so-called “cytokine storms,” that happen in coronavirus patients when their immune system goes into overdrive and does more damage than the virus itself.

So if you are suffering from soft tissue injury or tendonitis, give us a call today and see if Regenerative Medicine is right for you and meanwhile, we will wait to see what comes of the study on Coronavirus patients.

423-499-0003

#regenerativemedicine

#nomorepain